Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
NetherRealm guts Sektor and Cyrax in a desperate MK1 hotfix
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 56509, member: 636"] NetherRealm Studios reported that Mortal Kombat 1 achieved 6.2 million unit sales since September 2023, representing growth from the 5 million mark reached in January. Game Director Ed Boon announced these figures through social media while pledging continued efforts toward optimal game balance. The development team released a comprehensive hotfix addressing multiple fighter adjustments across the roster. Character modifications affected damage values, frame data, and move properties for fighters ranging from Ashrah to Sektor. The latest patch altered combo scaling, recovery times, and attack properties for various combatants. Notable changes affected popular characters like Liu Kang, Rain, and Reptile alongside newer additions such as Omni-Man and Conan. Sales performance trails behind Mortal Kombat 11, which reached 15 million copies by October 2022 after three and a half years. Despite positive critical reception and an 8.5 rating from Wccftech, the current title faces challenges matching its predecessor's commercial success with approximately 8.8 million additional units needed. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
NetherRealm guts Sektor and Cyrax in a desperate MK1 hotfix
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top